Log in

CVE:COVCovalon Technologies Stock Price, Forecast & News

0.00 (0.00 %)
(As of 05/26/2020 09:19 AM ET)
Today's Range
Now: C$1.65
50-Day Range
MA: C$1.76
52-Week Range
Now: C$1.65
Volume324 shs
Average Volume19,323 shs
Market CapitalizationC$42.60 million
P/E RatioN/A
Dividend YieldN/A
Covalon Technologies Ltd., an advanced medical technologies company, researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. The company has three proprietary platform technologies, including collagen matrix platform that is used to manufacture a family of products that treat chronic and infected wounds, such as diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; antimicrobial silicone adhesive platform, which is used in a family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone; and medical coating platform, a proprietary process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. It sells wound care dressing, surgical and peri-operative, and infection management products under the Covalon brand name. The company also offers development contracts, licensing agreements, and distribution contracts services. It provides its technologies, products, and services to various health care providers, such as hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.58 out of 5 stars

Industry, Sector and Symbol

Industry Biotechnology



Sales & Book Value

Annual SalesC$34.69 million
Cash FlowC$0.16 per share
Book ValueC$0.53 per share



Market CapC$42.60 million
Next Earnings Date5/26/2020 (Estimated)
OptionableNot Optionable

Receive COV News and Ratings via Email

Sign-up to receive the latest news and ratings for COV and its competitors with MarketBeat's FREE daily newsletter.

Covalon Technologies (CVE:COV) Frequently Asked Questions

How has Covalon Technologies' stock been impacted by COVID-19 (Coronavirus)?

Covalon Technologies' stock was trading at C$1.58 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, COV stock has increased by 4.4% and is now trading at C$1.65. View which stocks have been most impacted by Coronavirus.

When is Covalon Technologies' next earnings date?

Covalon Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, May 26th 2020. View our earnings forecast for Covalon Technologies.

How were Covalon Technologies' earnings last quarter?

Covalon Technologies Ltd (CVE:COV) issued its quarterly earnings results on Monday, March, 2nd. The company reported ($0.05) earnings per share (EPS) for the quarter. The firm earned $7.95 million during the quarter. View Covalon Technologies' earnings history.

Has Covalon Technologies been receiving favorable news coverage?

News stories about COV stock have trended negative recently, according to InfoTrie Sentiment. The research firm scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Covalon Technologies earned a news impact score of -2.1 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutCovalon Technologies.

Who are some of Covalon Technologies' key competitors?

What other stocks do shareholders of Covalon Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Covalon Technologies investors own include Shopify (SHOP), Carbon Black (CBLK), Great Canadian Gaming (GC), Canada Goose (GOOS), Kirkland Lake Gold (KL), Kinaxis (KXS), Lightspeed POS (LSPD), NIO (NIO), NVIDIA (NVDA) and Photon Control (PHO).

Who are Covalon Technologies' key executives?

Covalon Technologies' management team includes the following people:
  • Mr. Brian E. Pedlar, Pres, CEO & Director
  • Dr. Valerio DiTizio, Co-Founder, Chief Scientific Officer & VP (Age 51)
  • Mr. Danny Brannagan, Chief Financial Officer
  • Simon Smith, Chief Exec. Officer of Covalon Technologies Europe
  • Mr. Hamed Abbasian, VP of Bus. Devel.

What is Covalon Technologies' stock symbol?

Covalon Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "COV."

How do I buy shares of Covalon Technologies?

Shares of COV and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Covalon Technologies' stock price today?

One share of COV stock can currently be purchased for approximately C$1.65.

How big of a company is Covalon Technologies?

Covalon Technologies has a market capitalization of C$42.60 million and generates C$34.69 million in revenue each year.

What is Covalon Technologies' official website?

The official website for Covalon Technologies is www.covalon.com.

How can I contact Covalon Technologies?

Covalon Technologies' mailing address is 1660 Tech Ave Unit 5, MISSISSAUGA, ON L4W 5S7, Canada. The company can be reached via phone at +1-905-5688400.

This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.